Citi Pharma Limited (PSX:CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
73.53
+0.05 (0.07%)
At close: Jul 31, 2026

Citi Pharma Cash Flow Statement

Millions PKR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
1,097892.04833.46657.98653.69351.77
Depreciation & Amortization
186.39168.09138.2290.5976.8365.69
Loss (Gain) From Sale of Investments
323.17327.7-29.2835.124.48-
Provision & Write-off of Bad Debts
2.22.24.78---
Other Operating Activities
-294.23-404.1155.33-26.27136.3349.47
Change in Accounts Receivable
-683.46-885.74-282.69-480.58-957.02-145.08
Change in Inventory
-307.46-726.33-594.39-917.35-913.44113.53
Change in Accounts Payable
-948.1227.321,359260.08782.19-188.6
Change in Other Net Operating Assets
-66.1178.13-146.7951.42-106.03-22.38
Operating Cash Flow
-690.96-320.71,338-329-322.97224.4
Operating Cash Flow Growth
-----138.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-50.75-150.06-568.2-954.47-600.46-276.7
Investment in Securities
85.8742.3152.83179.77-312.12-
Other Investing Activities
1.19-5.233.43-6.13-8.91-
Investing Cash Flow
36.32-112.98-511.94-780.83-921.48-276.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
-1,470-1,246509.37122.8
Long-Term Debt Issued
----300146.95
Total Debt Issued
587.361,470-1,246809.37269.74
Short-Term Debt Repaid
--37.73-331.54---5
Long-Term Debt Repaid
--45.15-56.17-383.24-148.3-74.99
Total Debt Repaid
-38.83-82.89-387.7-383.24-148.3-79.99
Net Debt Issued (Repaid)
548.541,387-387.7863.24661.07189.75
Issuance of Common Stock
-----2,326
Common Dividends Paid
-799.61-739.82-571.15--311.54-
Other Financing Activities
-0.58-0.58---521.38521.38
Financing Cash Flow
-251.66646.82-958.86863.24-171.853,037

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Miscellaneous Cash Flow Adjustments
------0
Net Cash Flow
-906.31213.14-133.2-246.58-1,4162,985

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-741.71-470.77769.4-1,283-923.43-52.3
Free Cash Flow Growth
------
Free Cash Flow Margin
-5.36%-3.58%6.20%-10.35%-9.44%-0.90%
Free Cash Flow Per Share
-3.25-2.063.37-5.62-4.07-0.28
Levered Free Cash Flow
-821.01-567.3446.95-1,324-1,497759.74
Unlevered Free Cash Flow
-554.85-368.76631.59-1,240-1,461782.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
328.45356.83289.99329.358.7339.22
Cash Income Tax Paid
690.27574461.13367.92309.61126.46
Change in Working Capital
-2,005-1,307335.09-1,086-1,194-242.53